Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer

Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer

Abstract Background Tamoxifen (TAM) and Toremifene (TOR), two kinds of selective estrogen receptor modulators (SERMs), have equal efficacy in breast cancer patients. However, TAM has been proved to affect serum lipid profiles and cause fatty liver disease. The study aimed to compare the effects of T...

Full description

Bibliographic Details
Main Authors: Dandan Song, Yingying Hu, Biyu Diao, Rongrong Miao, Baodan Zhang, Yangjun Cai, Hanqian Zeng, Yuru Zhang, Xiaoqu Hu
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Cancer
Subjects:
Tamoxifen
Toremifene
Fatty liver
Lipid profiles
Online Access:https://doi.org/10.1186/s12885-021-08538-5

Internet

https://doi.org/10.1186/s12885-021-08538-5

Similar Items